Used primarily in the treatment of glaucoma, this compound helps reduce intraocular pressure by inhibiting carbonic anhydrase in the ciliary processes of the eye. This inhibition decreases the production of aqueous humor, thereby lowering pressure within the eye. It is commonly formulated as a topical ophthalmic solution and is often prescribed either alone or in combination with other antiglaucoma medications. Its localized action minimizes systemic side effects, making it a well-tolerated option for long-term management of open-angle glaucoma and ocular hypertension.